Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2011-07-26
2011-07-26
Crane, Lawrence E (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S456000, C536S028300, C549S403000
Reexamination Certificate
active
07985738
ABSTRACT:
Methods, uses, compositions and kits relating to the inhibition and/or prevention of undesirable cell proliferation, and prevention and/or treatment of diseases or disorders associated with such proliferation, such as cancer, using a cytosine nucleoside analog such as 5-aza-2′-deoxycytidine and an isoflavone such as genistein, are described.
REFERENCES:
patent: 5637703 (1997-06-01), Mazurek et al.
patent: 6613753 (2003-09-01), Rubinfeld et al.
patent: 6982253 (2006-01-01), Joshi-Hangal et al.
patent: 7135464 (2006-11-01), Joshi-Hangal et al.
patent: 00/03707 (2000-01-01), None
(R) Li et al., “Genistein Depletes Telomerase Activity Through Cross-talk Between Genetic and Epigenetic Mechanisms,” International Journal of Cancer, 125(2), 286-296 (2009).
(S) Fang et al., “Reversal of Hypermethylation and Reactivation of p16INK4a , RARβ, and MGMT Genes by Genistein and Other Isoflavones from Soy,” Clinical Cancer Research, 11(19), 7033-7041 (Oct. 1, 2005).
Raynal, N. J.-M. et al. Genistein, a Soy Isoflavone, Can Enhance the Antineoplastic Action of 5-AZA-2'Deoxycytidine on Leukemic Cells. The 11th International Conference on Differentiation Therapy, Nov. 4-8, 2006, France.
Raynal, N. J.-M. et al. La genisteine: une isoflavone du soja comme facteur de chemoprevention en sante environnementale. Journee de recherche, May 24, 2006. Montreal, Canada.
Shen, J. et al. Synergistic Antileukemia Effect of Genistein and Chemotherapy in Mouse Xenograft Model and potential mechanism through MAPK signaling. Exp Hematology, 2007, 35:pp. 75-83.
Issa et al., Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in hematopoietic malignancies, Blood, vol. 103, No. 5, pp. 1635-1640 (2004).
Raynal et al., Synergistic Effect of 5-Aza-2'-Deoxycytidine and Genistein in Combination Against Leukemia, Oncology Research, vol. 17, pp. 223-230 (2008).
Roper et al., Comparison of In Vitro Methods to Determine Drug-induced Cell Lethality, Cancer Research, vol. 36, pp. 2182-2188 (1976).
Charbonneau Michel
Momparler Louise F.
Momparler Richard Lewis
Raynal Noel Jean-Marie
Crane Lawrence E
Fish & Richardson P.C.
Institut National De La Recherche Scientifique
LandOfFree
Cytosine nucleoside analogs and isoflavones and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cytosine nucleoside analogs and isoflavones and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cytosine nucleoside analogs and isoflavones and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2650684